Bivi stock forecast 2025

BioVie didn't record any revenue over the last year, indicating that it's an early stage company still developing its business. Nonetheless, we can still examine its cash burn trajectory as part of our assessment of its cash burn situation. Even though it doesn't get us excited, the 46% reduction in cash burn year on year does suggest the company can continue operating for quite some time. Clearly, however, the crucial factor is whether the company will grow its business going forward. For that reason, it makes a lot of sense to take a look at our analyst forecasts for the company . TipRanks is a comprehensive research tool that helps investors make better, data-driven investment decisions. Momentum traders see upside in "BIVI stock forecast 2025" if biotech market indices maintain a positive trajectory. Volume spikes in August 2024 hinted at speculative pre-positioning. Watching for continuation patterns in Q4 could provide early entry signals ahead of key announcements.